ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
102 |
50K |
13 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
102
|
50K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
lowed
|
49 |
35K |
17 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
49
|
35K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
lowed
|
51 |
26K |
10 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
26K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
lowed
|
51 |
26K |
31 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
26K
|
31
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
lowed
|
56 |
31K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
31K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
7 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
1 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Completes Enrolment for TACTI-003 Phase IIb Trial
|
|
lowed
|
17 |
9.8K |
0 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
17
|
9.8K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
5 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
7 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
19 |
22/10/23 |
22/10/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
10 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
4 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
3 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: FDA supportive of Efti registrational trial in lung cancer
|
|
lowed
|
11 |
8.8K |
4 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
11
|
8.8K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
8 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
12 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
743 |
345K |
1 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
743
|
345K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
lowed
|
57 |
26K |
5 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
57
|
26K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
743 |
345K |
0 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
743
|
345K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
743 |
345K |
0 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
743
|
345K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
743 |
345K |
17 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
743
|
345K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
743 |
345K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
743
|
345K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
6 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
382 |
196K |
10 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
382
|
196K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
3 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
8 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
lowed
|
6 |
3.7K |
3 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
6
|
3.7K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Independent DMC recommends to continue TACTI-003 as planned
|
|
lowed
|
17 |
9.6K |
1 |
30/10/22 |
30/10/22 |
ASX - By Stock
|
17
|
9.6K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
6 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Ceasing to be a substantial shareholder from AEF
|
|
lowed
|
5 |
2.0K |
0 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Abstracts accepted for Presentation at SITC 2022
|
|
lowed
|
7 |
3.9K |
12 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
7
|
3.9K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
382 |
196K |
7 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
382
|
196K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: 2022 AGM & Key Dates
|
|
lowed
|
10 |
4.1K |
9 |
23/09/22 |
23/09/22 |
ASX - By Stock
|
10
|
4.1K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
382 |
196K |
5 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
382
|
196K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
9 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
382 |
196K |
1 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
382
|
196K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
lowed
|
41 |
22K |
14 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
41
|
22K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
The answer
|
|
lowed
|
20 |
10K |
4 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
20
|
10K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
The answer
|
|
lowed
|
20 |
10K |
0 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
20
|
10K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
The answer
|
|
lowed
|
20 |
10K |
1 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
20
|
10K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial
|
|
lowed
|
70 |
29K |
12 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
70
|
29K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
lowed
|
382 |
196K |
14 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
382
|
196K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Strategic communications plan
|
|
lowed
|
20 |
8.7K |
2 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
20
|
8.7K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
5 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
19 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
lowed
|
2.8K |
1.2M |
19 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ELCC 2022 abstract
|
|
lowed
|
44 |
21K |
16 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
44
|
21K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
lowed
|
43 |
21K |
4 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
43
|
21K
|
4
|
|